All
Combination Maintenance Therapy After Stem Cell Transplant May Prolong Survival in Multiple Myeloma
March 9th 2022Maintenance therapy with Ninlaro and Revlimid in patients with recently diagnosed multiple myeloma who underwent a stem cell transplant may safely improve survival, although more research is needed especially in high-risk patients.
Novel Monoclonal Antibody Injection May Address Significant Unmet Need in Patients With Rare Tumor
March 7th 2022As surgery is the current standard of care for patients with tenosynovial giant cell tumor, the potential to add another treatment option with fewer complications may dramatically help patients with this rare tumor.
FDA Approves Opdivo-Chemotherapy Regimen for Pre-Surgical Treatment of Non-Small Cell Lung Cancer
March 5th 2022The FDA’s approval of the Opdivo plus platinum-doublet chemotherapy regimen marks the agency’s first greenlight, according to manufacturer Bristol Myers Squibb, of an immunotherapy-based treatment in the pre-surgical setting for non-small cell lung cancer.
An Oncologist Steps ‘Further Into the Cancer World’ After Breast Cancer Diagnosis
March 3rd 2022The most revealing thing that Dr. Bhuvaneswari Ramaswamy, a breast medical oncologist, learned during her own treatment for breast cancer was that despite having extraordinary family and medical support, she still felt very isolated.
Long-Term Care of Myeloma May Not Be ‘One-Stop-Shop,’ Multidisciplinary Approach Can Help
March 3rd 2022As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about treating myeloma as a chronic disease and how the multidisciplinary approach to care can assist in challenges, like financial toxicity.